Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Editorial

Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Xu K, Tian X, Yang Y, et al

Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage

Thorax 2018;73:308-310.